MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. TTEC
5. DAL
6. AWK
7. SPCX
8. III
9. TEVA
10. FCLI

Go back to MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
(NASDAQ: MTVA) Delayed: 1.60 -0.11 (6.43%)
Previous Close $1.71    52 Week High $ 
Open $1.71    52 Week Low $ 
Day High $1.71    P/E N/A 
Day Low $1.57    EPS $ 
Volume 181,685